125 related articles for article (PubMed ID: 15632911)
1. Survival outcomes for second primary head and neck cancer: a matched analysis.
Bhattacharyya N; Nayak VK
Otolaryngol Head Neck Surg; 2005 Jan; 132(1):63-8. PubMed ID: 15632911
[TBL] [Abstract][Full Text] [Related]
2. A matched survival analysis for squamous cell carcinoma of the head and neck in the elderly.
Bhattacharyya N
Laryngoscope; 2003 Feb; 113(2):368-72. PubMed ID: 12567097
[TBL] [Abstract][Full Text] [Related]
3. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes for head and neck squamous cell carcinoma arising after lymphoma.
Moore MG; Bhattacharyya N
Otolaryngol Head Neck Surg; 2008 Mar; 138(3):388-93. PubMed ID: 18312890
[TBL] [Abstract][Full Text] [Related]
5. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases.
Rennemo E; Zätterström U; Boysen M
Laryngoscope; 2008 Aug; 118(8):1350-6. PubMed ID: 18496157
[TBL] [Abstract][Full Text] [Related]
6. Survival after surgical resection of pulmonary metastases and second primary squamous cell lung carcinomas in head and neck cancer.
Geurts TW; Balm AJ; van Velthuysen ML; van Tinteren H; Burgers JA; van Zandwijk N; Klomp HM
Head Neck; 2009 Feb; 31(2):220-6. PubMed ID: 18972427
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of 71 cases of multiple primary cancers in head and neck squamous carcinomas].
Zhou YQ; Li XM; Gao CM; Zhao QL; Li GS; Cheng JM; Shang YD
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):232-6. PubMed ID: 15283285
[TBL] [Abstract][Full Text] [Related]
9. Second primary lung cancers following a diagnosis of primary head and neck cancer.
Griffioen GH; Louie AV; de Bree R; Smit EF; Paul MA; Slotman BJ; Leemans CR; Senan S
Lung Cancer; 2015 Apr; 88(1):94-9. PubMed ID: 25662386
[TBL] [Abstract][Full Text] [Related]
10. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
[TBL] [Abstract][Full Text] [Related]
11. Impact of second primary esophageal or lung cancer on survival of patients with head and neck cancer.
Chen MC; Huang WC; Chan CH; Chen PT; Lee KD
Oral Oncol; 2010 Apr; 46(4):249-54. PubMed ID: 20138797
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of head and neck cancer with retinoids: a negative result.
Perry CF; Stevens M; Rabie I; Yarker ME; Cochrane J; Perry E; Traficante R; Coman W
Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):198-203. PubMed ID: 15781758
[TBL] [Abstract][Full Text] [Related]
13. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
[TBL] [Abstract][Full Text] [Related]
14. Primary and second primary cancer in 649 patients with malignancies of the maxillofacial region.
Friedrich RE
Anticancer Res; 2007; 27(4A):1805-18. PubMed ID: 17649777
[TBL] [Abstract][Full Text] [Related]
15. Survival in second primary malignancies of patients with head and neck cancer.
Di Martino E; Sellhaus B; Hausmann R; Minkenberg R; Lohmann M; Esthofen MW
J Laryngol Otol; 2002 Oct; 116(10):831-8. PubMed ID: 12437840
[TBL] [Abstract][Full Text] [Related]
16. 25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province.
Tiwana MS; Wu J; Hay J; Wong F; Cheung W; Olson RA
Oral Oncol; 2014 Jul; 50(7):651-6. PubMed ID: 24731736
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.
Duprez F; Madani I; Bonte K; Boterberg T; Vakaet L; Derie C; De Gersem W; De Neve W
Radiother Oncol; 2009 Dec; 93(3):563-9. PubMed ID: 19919885
[TBL] [Abstract][Full Text] [Related]
18. Second course of radiation for new primary head-and-neck cancer: population-based study of survival.
Milano MT; Zhang H
Am J Clin Oncol; 2011 Aug; 34(4):367-71. PubMed ID: 20859195
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.
Homann N; Nees M; Conradt C; Dietz A; Weidauer H; Maier H; Bosch FX
Clin Cancer Res; 2001 Feb; 7(2):290-6. PubMed ID: 11234882
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
